Evidence map›Paper›PMID 20717737›Full record

ReviewJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2011

Neuroimmune pharmacology from a neuroscience perspective.

Nicole A Northrop, Nicole A Northrup, Bryan K Yamamoto

Erratum issuedAbstract readReview
In one paragraph

Review in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Advances in Neuroimmunology.Brain sciences · 2017
    Article
  6. Review
  7. Review
  8. Review
  9. Education Mission for Neuroimmune PharmacologyJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2011
    Article
4 · The record

Corrections and comments

  • Erratum issued
    Northrup, Nicole A [corrected to Northrop, Nicole A]
5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nicole A NorthropDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA.
Nicole A Northrup
Bryan K Yamamoto
Boston University · USUniversity of Toledo · US

Funding

METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATER01DA007606 · NIDA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI YAMAMOTO, BRYAN K · 1992 to 2016
$5.1M
Methamphetamine, Stress and Brain EndotheliumR01DA035499 · NIDA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI YAMAMOTO, BRYAN K · 2013 to 2017
$2.2M
Chronic Stress and MDMA NeurotoxicityR01DA016866 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI YAMAMOTO, BRYAN K · 2003 to 2006
$1.3M
Role of Tyrosine in MDMA ToxicityR01DA019486 · NIDA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI YAMAMOTO, BRYAN K · 2006 to 2010
$1.3M
NIDA NIH HHS DA07606NIDA NIH HHS DA16866NIDA NIH HHS DA19486NIDA NIH HHS R01 DA007606NIDA NIH HHS R01 DA016866NIDA NIH HHS R01 DA019486NIDA NIH HHS R01 DA035499
6 · The paper itself

Abstract

The focus of this commentary is to describe how neuroscience, immunology, and pharmacology intersect and how interdisciplinary research involving these areas has expanded knowledge in the area of neuroscience, in particular. Examples are presented to illustrate that the brain can react to the peripheral immune system and possesses immune function and that resident immune molecules play a role in normal brain physiology. In addition, evidence is presented that the brain immune system plays an important role in mediating neurodegenerative diseases, the aging process, and neurodevelopment and synaptic plasticity. The identification of these mechanisms has been facilitated by pharmacological studies and has opened new possibilities for pharmacotherapeutic approaches to the treatment of brain disorders. The emerging field of neuroimmune pharmacology exemplifies this interdisciplinary approach and has facilitated the study of basic cellular and molecular events and disease states and opens avenues for novel therapies.

Indexed as

Allergy and ImmunologyNeurosciencesPharmacologyAnimalsBrainHumansNeuroimmunomodulation

Identifiers

PMID20717737
PMCPMC3988456
OpenAlexW2058017449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.